Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie J Paik

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Current Opinion in Rheumatology|August 23, 2016
Myopathy in scleroderma and in other connective tissue diseasesJulie J Paik
Current Opinion in Rheumatology|August 28, 2018
Muscle disease in sclerodermaJulie J Paik
Best Practice & Research. Clinical Rheumatology|February 13, 2020
Inflammatory muscle disease - An updateSara Baig, Julie J Paik
Frontiers in Immunology|August 1, 2025
Emerging B and plasma cell-targeting immune therapies in idiopathic inflammatory myopathiesMarwin Groener, Julie J Paik
Rheumatic Diseases Clinics of North America|October 29, 2025
Myositis in 2025: Defining Subtypes, Closing Gaps, and Shaping the FutureJulie J Paik, Tahseen Mozaffar
Seminars in Arthritis and Rheumatism|September 20, 2016
A case of refractory dermatomyositis responsive to tofacitinibJulie J Paik, Lisa Christopher-Stine
Current Treatment Options in Rheumatology|April 23, 2024
Past, Present, and Future in Dermatomyositis TherapeuticsMelody P Chung, Julie J Paik
The Journal of Allergy and Clinical Immunology|May 14, 2022
SARS-CoV-2 vaccination in the immunocompromised hostCaoilfhionn M Connolly, Julie J Paik
Current Rheumatology Reports|August 27, 2020
Promising and Upcoming Treatments in MyositisLauren N Smith, Julie J Paik
The Lancet. Rheumatology|July 14, 2021
Impact of methotrexate on first-dose COVID-19 mRNA vaccinationCaoilfhionn M Connolly, Julie J Paik
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Current Opinion in Rheumatology|August 23, 2016
Myopathy in scleroderma and in other connective tissue diseasesJulie J Paik
Current Opinion in Rheumatology|August 28, 2018
Muscle disease in sclerodermaJulie J Paik
Best Practice & Research. Clinical Rheumatology|February 13, 2020
Inflammatory muscle disease - An updateSara Baig, Julie J Paik
Frontiers in Immunology|August 1, 2025
Emerging B and plasma cell-targeting immune therapies in idiopathic inflammatory myopathiesMarwin Groener, Julie J Paik
Rheumatic Diseases Clinics of North America|October 29, 2025
Myositis in 2025: Defining Subtypes, Closing Gaps, and Shaping the FutureJulie J Paik, Tahseen Mozaffar
Seminars in Arthritis and Rheumatism|September 20, 2016
A case of refractory dermatomyositis responsive to tofacitinibJulie J Paik, Lisa Christopher-Stine
Current Treatment Options in Rheumatology|April 23, 2024
Past, Present, and Future in Dermatomyositis TherapeuticsMelody P Chung, Julie J Paik
The Journal of Allergy and Clinical Immunology|May 14, 2022
SARS-CoV-2 vaccination in the immunocompromised hostCaoilfhionn M Connolly, Julie J Paik
Current Rheumatology Reports|August 27, 2020
Promising and Upcoming Treatments in MyositisLauren N Smith, Julie J Paik
The Lancet. Rheumatology|July 14, 2021
Impact of methotrexate on first-dose COVID-19 mRNA vaccinationCaoilfhionn M Connolly, Julie J Paik
Pageof 14